In vitro effect of serum IgGs with oxidoreductase activities of schizophrenic patients on apoptosis level-Reference-Cited by-同舟云学术

In vitro effect of serum IgGs with oxidoreductase activities of schizophrenic patients on apoptosis level

Published:2023-03-18 Issue:3 Volume: Page:225-234
ISSN:2074-6822
Container-title:Vestnik nevrologii, psihiatrii i nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
language:
Short-container-title:Bulletin of Neurology, Psychiatry and Neurosurgery

Author:

Smirnova L.P.^ORCID, ,Epimakhova E.V.^ORCID,Kazantseva D.V.^ORCID,Kamaeva D.A.^ORCID,Semke A.V.^ORCID,Ivanova S.A.^ORCID, , , , , ,

Abstract

This paper presents the results of a study of the effect of IgG with catalase and superoxide dismutase activities, isolated from the blood serum of patients with paranoid schizophrenia, on the parameters of apoptotic cell death in an in vitro experiment, using a model of the SH-SY5Y human neuroblastoma cell line. The catalase and superoxide dismutase activities of immunoglobulins G were evaluated, and these activities were proved to belong to antibodies. It has been shown for the first time that abzymes from patients with schizophrenia in the therapeutic remission phase significantly reduce the level of apoptosis in the SH-SY5Y human neuroblastoma cell line after 24 incubations in an in vitro experiment.

Publisher

PANORAMA Publishing House

Subject

General Medicine

Reference31 articles.

1. 1. Gurovich I.Ia., Shmukler A.B., Storozhakova Ia.A. Remissii i lichnostno-sotsialnoe vosstanovlenie (recovery) pri shizofrenii: predlozheniia k 11 peresmotru MKB [Remissions and personal-social recovery (recovery) in schizophrenia: proposals for the 11th revision of the ICD] // Sotsialnaia i klinicheskaia psikhiatriia [Social and Clinical Psychiatry]. - 2008. - Vol. 18. - No. 4. - P. 34-39. (In Russ.)

2. 2. Ermakov E.A., Dmitrieva E.M., Parshukova D.A., Kazantseva D.V., Vasilieva A.R., Smirnova L.P. Oxidative stress-related mechanisms in schizophrenia pathogenesis and new treatment perspectives // Oxidative Medicine and Cellular Longevity. - 2021. - Vol. 2021.

3. 3. Tsygankov B. Complications and adverse effects of neuroleptic therapy for patients with schizophrenia: clinic, prognosis and correction // Psychiatria Danubina. - 2019. - Vol. 31. - №. suppl 4. - P. 706-706.

4. 4. Nevinsky G.A., Buneva V.N. Natural catalytic antibodies in norm, autoimmune, viral, and bacterial diseases // The Scientific World Journal. - 2010. - Vol. 10. - Article №. 820417.

5. 5. Tolmacheva A.S., Nevinsky G.A. Essential Protective Role of Catalytically Active Antibodies (Abzymes) with Redox Antioxidant Functions in Animals and Humans // International Journal of Molecular Sciences. - 2022. - Vol. 23. - №. 7. - P. 3898.